CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase-Reference-Cited by-同舟云学术

CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase

Published:2015-10-21 Issue:7575 Volume:526 Page:710-714
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

He Weiwei,Bai Ge,Zhou Huihao,Wei Na,White Nicholas M.,Lauer Janelle,Liu Huaqing,Shi Yi,Dumitru Calin Dan,Lettieri Karen,Shubayev Veronica,Jordanova Albena,Guergueltcheva Velina,Griffin Patrick R.,Burgess Robert W.,Pfaff Samuel L.,Yang Xiang-Lei

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature15510.pdf

Reference41 articles.

1. Saxena, S. & Caroni, P. Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron 71, 35–48 (2011)

2. Skre, H. Genetic and clinical aspects of Charcot-Marie-Tooth’s disease. Clin. Genet. 6, 98–118 (1974)

3. Patzkó, A. & Shy, M. E. Update on Charcot-Marie-Tooth disease. Curr. Neurol. Neurosci. Rep. 11, 78–88 (2011)

4. Antonellis, A. et al. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am. J. Hum. Genet. 72, 1293–1299 (2003)

5. Wakasugi, K. & Schimmel, P. Two distinct cytokines released from a human aminoacyl-tRNA synthetase. Science 284, 147–151 (1999)

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Treatment Methods for Charcot–Marie–Tooth Diseases;Biomolecules;2024-09-09

2. Comprehensive assessment of recessive, pathogenicAARS1alleles in a humanized yeast model reveals loss-of-function and dominant-negative effects;2024-06-24

3. Boosting BDNF in muscle rescues impaired axonal transport in a mouse model of DI-CMTC peripheral neuropathy;Neurobiology of Disease;2024-06

4. Molecular functions of moonlighting proteins in cell metabolic processes;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-01

5. Targeting muscle to treat Charcot-Marie-Tooth disease;Neural Regeneration Research;2023-12-11